View RSS Feed

TheNews

Bristol Myers Squibb Stock Is Likely To Offer Better Returns Over This Life Sciences Company

Rate this Entry
0 Comments
by
TheNews
, 03-19-2022 at 12:09 PM (954 Views)
      
   
Name: bmy-d1-just2trade-online-ltd.png Views: 68 Size: 16.5 KB

We think that Bristol Myers Squibb stock (NYSE: BMY) currently is a better pick compared to its industry peer Bio-Rad Laboratories stock (NYSE: BIO), a life sciences company, given its better growth prospects and comparatively lower valuation of 3.3x trailing revenues, compared to 5.7x for Bio-Rad..

Name: bio-d1-just2trade-online-ltd.png Views: 93 Size: 16.0 KB

more...

Submit "Bristol Myers Squibb Stock Is Likely To Offer Better Returns Over This Life Sciences Company" to Google Submit "Bristol Myers Squibb Stock Is Likely To Offer Better Returns Over This Life Sciences Company" to del.icio.us Submit "Bristol Myers Squibb Stock Is Likely To Offer Better Returns Over This Life Sciences Company" to Digg Submit "Bristol Myers Squibb Stock Is Likely To Offer Better Returns Over This Life Sciences Company" to reddit

Categories
Uncategorized

Comments